Chinese American Cancer Survivors Writing Study

Running, not enrolling · Not applicable

Conditions studied: Cancer

In brief

The Chinese American Cancer Survivors Writing Study is a Randomized Controlled Trial (RCT) testing the feasibility and efficacy of the Expressive Helping (EH) intervention among Chinese American cancer survivors.

Key facts

Study ID

NCT05456100

Run by

New York University

People needed

108

Starts

2022-07-14

Expected to finish

2026-12-31

Last updated by the study team

2026-06-12

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Over 18 years old.
• Prefer speaking in Mandarin Chinese or Cantonese, and able to read and write Simplified or Traditional Chinese.
• Within 5 years after completing primary treatment or have completed primary treatment but still on medication for managing cancer-related symptoms.

You may not qualify if…

• Difficulties with writing
• Current active participation in support groups (i.e., attending more than once per week)

Where it is running

• New York University — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.